With the emergence and long-term Impact of COVID-19, Global Blood Screening Market to reach USD XXX Million by 2030
Bizwit Research & Consulting LLP’s recent analysis on the Global Blood Screening Market points towards a potential rise to USD XXX Million by 2030. Blood screening, also known as blood tests or blood work, is a medical procedure that involves analyzing a sample of a person’s blood to assess various aspects of their health. It is a valuable tool in healthcare for diagnosing, monitoring, and managing a wide range of medical conditions. The key factors driving the market growth increasing blood donation, rising prevalence of blood-borne diseases, growing healthcare infrastructure, and increasing aging population are anticipated to support market growth.
Geographically, the global Blood Screening market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in 2022 owing to the enhanced screening accuracy, prevalence of key market players, and rising prevalence of blood-borne diseases. Whereas, Asia Pacific is expected to grow with the fastest growth rate during the forecast period, owing to factors such as the growing healthcare infrastructure, public health initiatives, growing prevalence of blood-borne diseases, and increasing blood donation.
The global Blood Screening market is highly competitive owing to the presence of several key players such as Bio-Rad Laboratories, Inc. Grifols, S.A. F. Hoffmann-La Roche Ortho Clinical Diagnostics Becton, Dickinson and Company (BD) DiaSorin S.p.A. Thermo Fisher Scientific Inc. Abbott QUOTIENT Limited Beckman Coulter, Inc, and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Blood Screening Market is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2023-2030.
- In the Product Type segment, Instruments emerged out as the leading market segment in 2022.
- North America is anticipated to drive regional growth owing to the enhanced screening accuracy, prevalence of key market players, and rising prevalence of blood-borne diseases.
- Asia Pacific is expected to grow at higher rate followed by Europe during 2023-2030.
Bizwit Research & Consulting has considered following segments for the study:
By Product Type:
- Instruments
- Reagents & Kits
By Technology:
- Molecular Tests
- Serology Tests
By End User:
- Independent Clinical Laboratories
- Hospital-based Laboratories
- Others
Regional Outlook
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com
About Us
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Contact US
Global Business Development
Phone: +1 209 498-3066
Email: Sales@bizwitresearch.com
Website: www.bizwitresearch.com
